Biogen Inc. diskutieren
Biogen Inc.
WKN: 789617 / Symbol: BIIB / Name: Biogen / Aktie / Pharmazeutika / Large Cap /
208,90 €
0,58 %
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $327.00 to $312.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Wells Fargo & Company from $343.00 to $365.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $351.00 to $363.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $314.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $361.00 to $373.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Stifel Nicolaus from $315.00 to $287.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Oppenheimer Holdings Inc. from $280.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $295.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $363.00 to $379.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $325.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $364.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $295.00 to $290.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $295.00 to $285.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Piper Sandler from $350.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Robert W. Baird from $333.00 to $316.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $311.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Neueste Beiträge
Plodder in Apple Inc. diskutieren